Cancer Medicines Forum: June 2022

• Date:
  Tuesday, 28 June 2022
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The EMA's Cancer Medicines Forum (CMF) aims to explore how EMA can contribute towards addressing remaining uncertainties about the use of cancer medicines in clinical practice.

The forum brings together representatives of academic organisations from EMA’s Healthcare Professionals Working Party and the European medicines regulatory network. 

The results of discussions will support the prioritisation of actions to fight cancer in EMA's Regulatory Science Strategy to 2025 and Academia Collaboration Matrix Action Plan.

The meetings of the forum are by invitation only.

EMA launched the CMF together with the European Organisation for Research and Treatment of Cancer (EORTC) in March 2022.

EMA will review the composition and procedures of the forum after a one-year pilot phase.

Documents

Minutes of the Cancer Medicines Forum - 26 February 2024

Presentation - pragmatic clinical trials : Preliminary shared experience under the CTR (D. Lacombe, EORTC)

Presentation - factors affecting the feasibility of post-authorization RCTs for conditionally authorized anticancer medicines (C. van Hattem, A. de Jong, L. Bloem, Utrecht University)